oral glp-1 weight loss 3 Takeaways from the Landmark 'Switch' Trial for Obesity Care WLP-1™: GLP-1 Benefits, No Needles,
Description
& Pollock, C
2018;91:e139-42
Jarred Dudding, GLP-1 Receptor Agonists: A Changing Landscape FDA Rescinds Shortage Designation , 122 Mo
Its a tri-agnoist which activates the GLP-1 receptor, the GIP receptor, and the glucagon receptor and looks quite remarkable in clinical trials, showing upwards of 24% body weight loss in patients. The delivery methods of these drugs are also evolving
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
That's why comprehensive care mattersnutrition, coaching, training, and even bariatric surgery when needed
